CooperSurgical, Inc.
$1.9M 9,542 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation reported $1,926,449.11 across General Payments, Research, and Ownership to 8,013 physicians and teaching hospitals across 8,040 transactions.
- $1.9M Top quartile payer
- All-tracks total
- 8,040 Top quartile volume
- Transactions
- 8,013 Top quartile reach
- Recipients
- +$274.9K
- General Payments vs PY2023
PROCEPT BioRobotics Corporation reported $1,926,449.11 across all CMS Open Payments tracks (General + Research + Ownership) to 8,013 physicians and teaching hospitals in Program Year 2024 - ranking #455 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,735,650.61, averaging $240.42 per recipient.
How PROCEPT BioRobotics Corporation's $1.9M all-tracks total breaks down
PROCEPT BioRobotics Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
D
64/100
Total payments
F
28/100
Transaction volume
C
68/100
Physician reach
C
71/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer procept-biorobotics-corporation PROCEPT BioRobotics Corporation
$1.9M · #455/1,925 · 0.0% industry · PY2024
- TOT $1.9M
- RANK #455
- SHARE 0.0%
- TXN 8,040
- RCP 8,013
- CAT 7
- GEN $1.7M
- ΔGEN +$274.9K
- TOP1 11.3%
- PY 2024
Volume peers
Nearest volume peer: CooperSurgical, Inc. ($1.9M)
PROCEPT BioRobotics Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
PROCEPT BioRobotics Corporation's CMS-reported General Payments increased by $274.9K (+18.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PROCEPT BIOROBOTICS CORPORATIONPY2023: PROCEPT BIOROBOTICS CORPORATIONPY2024: PROCEPT BioRobotics Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,460,744.03
- PY2024
- $1,735,650.61
What the Data Shows for PROCEPT BioRobotics Corporation
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For PROCEPT BioRobotics Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $930.8K, accounting for 53.6% of this company's General Payments and 213 transactions.
General Payment Breakdown by Type
Across 7 types of general payments, PROCEPT BioRobotics Corporation's largest category was "Consulting Fee" at $930.8K - 53.6% of General Payments.
PROCEPT BioRobotics Corporation reports 7 general-payment categories - the top three are Consulting Fee (53.6%), Food and Beverage (23.6%), and Travel and Lodging (15.8%). The remaining 4 categories make up 7.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How PROCEPT BioRobotics Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $930.8K | 213 | 53.6% |
| Food and Beverage | $408.9K | 6,715 | 23.6% |
| Travel and Lodging | $274.6K | 1,067 | 15.8% |
| Compensation for Services Other Than Consulting | $110.1K | 8 | 6.3% |
| Long-Term Medical Supply or Device Loan | $9.9K | 1 | 0.6% |
| Gift | $1.2K | 1 | 0.1% |
| Education | $250.00 | 8 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $702,529.32 (40.5%) of $1,735,650.61 in this company's General Payments records across 3,745 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for PROCEPT BioRobotics Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Ravi Munver
$195,767.61 across 144 reported transactions
- 2
Lewis Kriteman
$182,255.69 across 91 reported transactions
- 3
Brian Helfand
$128,420.20 across 115 reported transactions
- 4
David Cuellar
$114,499.85 across 84 reported transactions
- 5
Frederic Moll
$81,585.97 across 10 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
PROCEPT BioRobotics Corporation ranks #455 of 1,925 by total payments (top 24% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,371 of 1,838 by HHI (bottom 25% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- OsteoCentric Technologies, Inc. : $303.4K total payments, HHI 412
- Integrity Implants Inc. dba Accelus : $1.6M total payments, HHI 412
- Provepharm Inc. : $41.4K total payments, HHI 411
- TriSalus Life Sciences, Inc. : $443.3K total payments, HHI 411
- Tarsus Pharmaceuticals, Inc. : $5.3M total payments, HHI 409
- Roche Diagnostics Corporation : $552.8K total payments, HHI 407
- PROCEPT BioRobotics Corporation (this company) : $1.7M total payments, HHI 405
- Cerapedics Inc. : $796.4K total payments, HHI 405
- Shorla Oncology Inc. : $797.92 total payments, HHI 404
- Providence Medical Technology, Inc. : $467.9K total payments, HHI 404
- icotec Medical Inc. : $393.7K total payments, HHI 403
- Shionogi Inc : $1.4M total payments, HHI 403
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as PROCEPT BioRobotics Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about PROCEPT BioRobotics Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with PROCEPT BioRobotics Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Procyrion, Inc.
$1.9M 211 recipients
Compare payment profiles
Vasorum USA Inc.
$1.9M 59 recipients
Compare payment profiles
Acrotech Biopharma Inc.
$1.9M 1,589 recipients
Compare payment profiles
Applied Medical Resources Corporation
$1.9M 2,197 recipients
Compare payment profiles
Spark Therapeutics, Inc.
$1.9M 146 recipients
Compare payment profiles
Put this to use
PROCEPT BioRobotics Corporation ranks #455 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where PROCEPT BioRobotics Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just PROCEPT BioRobotics Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.